Form4insider filings, from the source

Insider · CIK 0001883821

Jason Haas

Files at: LGND. On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $3.7M · 2net −$3.7M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesJun 11Jun 21Jul 2Jul 12Jul 23Aug 2Aug 13

Reported trades — common stock

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Aug 12, 2026 SForm 4 →Aug 14, 5:04 pm EDTLIGAND PHARMACEUTICALS INCLGND7,138$292.81$2,090,0623,981−64.2%
Aug 12, 2026 MForm 4 →Aug 14, 5:04 pm EDTLIGAND PHARMACEUTICALS INCLGND6,138$51.56$316,47511,119—
Jun 12, 2026 SForm 4 →Jun 15, 9:06 pm EDTLIGAND PHARMACEUTICALS INCLGND6,461$255.58$1,651,3204,981−56.5%
Jun 12, 2026 MForm 4 →Jun 15, 9:06 pm EDTLIGAND PHARMACEUTICALS INCLGND4,000$51.56$206,24011,442—
Jun 5, 2026 AForm 4 →Jun 9, 7:35 pm EDTLIGAND PHARMACEUTICALS INCLGND836——7,442—

Reported trades — derivatives (options, RSUs, warrants)

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Aug 12, 2026 MForm 4 →Aug 14, 5:04 pm EDTLIGAND PHARMACEUTICALS INCLGND6,138——0—
Jun 12, 2026 MForm 4 →Jun 15, 9:06 pm EDTLIGAND PHARMACEUTICALS INCLGND4,000——6,138—
Jun 5, 2026 AForm 4 →Jun 9, 7:35 pm EDTLIGAND PHARMACEUTICALS INCLGND2,938——2,938—